The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Even the most simple search shows these companies have two different names and are at addresses 160 miles apart - what’s the link?
Hello RKB,
I wonder if you realise the cost implications of your complaints? Anything the NOMAD has to approve comes with costs, plus there will be a legal review, again fees to DLA Piper. The audit process, which includes auditing RNS announcements and transactions should catch any errors and may require a restatement, however I think the adjustment will fall far below any measure of materiality, and it may not be necessary for a specific correction. If it is felt necessary to make a correction I would expect a sentence added to a future RNS or update to clarify the discrepancy between the announced price and the calculated price paid by JL.
Educated alternate points of views are welcome. But I’m not convinced you have the welfare of TNT’s shareholders at heart.
I disagree that a company is better run if they publish results more quickly than the deadline requires - it doesn’t really make any sense, it just means the company and the auditor have more resources dedicated to the audit. There’s a balance between the cost (in cash and opportunity cost) of delivering an audit and what the benefit of doing it quickly would be. How quickly something is done is not a reliable reflection on the quality of the auditors.
At least if he reads it he’ll realise that it’s not for him and take his opinions elsewhere…
It was my reply in fact. You ask a few questions, but the answers are already out there - read Allenby’s note published in January and Tintra’s own roadmap to launch and beyond. Auditors generally determine the timetable of the audit, and often they like to take all the available time to complete the audit itself and go through the technical and partner review. Last year there was a qualification in the accounts that would have added significant time to the process and review.
How many share do you have? Not sure you can change the Nomad just because he hasn’t got back to you yet? I can’t see you listed under AIM 26 as having a significant holding. If you are part of a concert party then you should declare it - you and your three friends perhaps? But I can’t see enough buys to get your foot in the door?
Are you a TNT shareholder RKB or just interested in what’s happening?
I think a correction in the minor difference of the price paid by JL doesn’t need the expense of a separate RNS, but if needed, should be corrected in a future announcement. I don’t think it’s material in itself, but should be corrected in due course if it was inaccurate.
A bit more about the recently awarded patent is on the Tintra PLC blog:
https://tintra.com/2023/03/tintras-revolutionary-banking-infrastructure-first-patent-paves-the-way-for-financial-and-social-inclusion/
The patent (number 11615399) is searchable and makes interesting reading - the ability to link non-regulated wallets to regulated platforms:
“This invention relates, in general, to a client authentica- ton process establishing account associations across mu-l tiple independent and disparate platforms. Particularly, but not exclusively, the invention is applicable a method and system that obfuscates and authenticates personal data that otherwise would eb necessarily communicated over an open public network supporting third generation internet services,
such as web 3.0 and generally an unregulated environment, in order to secure access to third-party services”.
Peace and love. Look after yourself.
(Somewhat less than) 15% at 8% discount is the WCS - but not anything like a resources company at 50% to 100% discount.
So what? The deal was done.
Monet raised at a 10X premium after that.
In any case, we have to live with it.
If it’s not for you, cut your losses.
And usual armchair CEO comments from you.
Nothing constructive to offer.
*It’s nothing like - I sound like a Bristolian….
It’s not nothing like pharma that needs 1bn+ to launch a product.
Traders came in thinking they were buying £20 notes for a fiver, then they are surprised that it takes a little more to build a bank.
Money raised at 1178p.
Strong team.
The gap will close.
Absolutely daft - IPO costs are huge. Just sell up and go elsewhere….
Wrong, also dilution risk here is relatively low…
Both before markets opened on 16th December.
The additional structured share deal was announced before the market opened on 16 December at over £4. PI’s and short term traders crashed the price, MM’s valued the deal at three times today’s price.
There would only be an RNS if there is an issue, and it would have already happened. No links to SVB.